Virongy Biosciences Inc
UnclaimedIn-Vitro Diagnostic Substance ManufacturingManassas, VA
Founded
2021
Primary NAICS
325413
CAGE code
99T06
Federal awards
$11.7K
Overview
Virongy Biosciences is focused on creating tools and platforms for high-risk viral pathogens and viral-based gene therapy.
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- In-Vitro Diagnostic Substance Manufacturing325413
Capabilities
Biological Product (except Diagnostic) ManufacturingResearch and Development in Biotechnology (except Nanobiotechnology)Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)General Science and Technology R&D Services; General Science and Technology; Applied ResearchGeneral Science & Technology R&D Svcs; General Science & Technology; Experimental DevelopmentSpecial Studies/Analysis- Scientific Data
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2023 | Department of Health and Human Services | $11,691 | 1 |